Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Load latest

Biocon Ltd.

27 Apr 2023

358.75

-0.21%

Corp. Note

BIOCON LTD. - 532523 - Format of the Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBIOCON LTD. 2CIN NO.L24234KA1978PLC003417 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1070.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Mayank Verma Designation: Company Secretary and Compliance Officer EmailId: mayank.verma101@biocon.com Name of the Chief Financial Officer: Indranil Sen Designation: Chief Financial Officer EmailId: indranil.sen@biocon.com Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Biocon Ltd.

26 Apr 2023

358.75

-0.21%

Board Meeting

BIOCON LTD. - 532523 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

The Board of Directors of Biocon Limited at its meeting held today, i.e. on Wednesday, April 26, 2023, has approved the transaction for issuance of Secured, Redeemable, NCDs aggregating upto Rs. 500 crores on private placement basis to ESOF III Investment Fund managed by Edelweiss Alternate Asset Advisors Limited (EAAA) and EAAA. The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%. The proceeds from the NCDs will be further invested by Biocon Limited as OCDs in BBL on similar terms as the NCDs. The Board of Directors of BBL has considered and approved the execution of the transaction documents for issuance of CCDs of BBL aggregating upto Rs. 300 crores to Investors. CCDs will convert to 1:1 BBL shares with a contingent coupon to guarantee minimum 12% IRR. The consummation of above transactions are subject to customary regulatory approvals and conditions precedent. The Board Meeting commenced at 8:45 pm and concluded at 9:20 pm.

pdf

Biocon Ltd.

25 Apr 2023

358.75

-0.21%

Serum arm to double investment in Biocon unit

livemint

This is an addition to Serum's previous investment in November 2022, when it invested $150 million for a stake in the biosimilar subsidiary.

Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.

Serum Institute of India doubles Biocon investment to $300 million

Business Standard | 25 Apr 2023 8 more

Biocon Ltd.

25 Apr 2023

358.75

-0.21%

Company Update

BIOCON LTD. - 532523 - Notification

BSE India

Please find enclosed a notification titled 'Serum & Biocon Biologics Agree to Restructure Equity Investment'. The above information will also be available on the website of the Company at www.biocon.com.

pdf

Biocon Ltd.

24 Apr 2023, 01:07AM

358.75

-0.21%

Biocon to consider issuance of NCDs on private placement basis on April 26

livemint

Biocon Biologics Sunday said that it would hold a meeting of Board of Directors on April 26, 2023 to consider issuance of secured, redeemable, non-convertible debentures (NCDs) on private placement basis

Biocon Ltd. has an average target of 367.20 from 5 brokers.

Biocon Ltd.

23 Apr 2023, 09:19PM

358.75

-0.21%

Board Meeting

BIOCON LTD. - 532523 - Board Meeting Intimation for Intimation Pursuant To Regulation 29(1)(D) Of SEBI …

BSE India

BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, April 26, 2023, inter alia, to consider the issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis, investment in securities to be issued by Biocon Biologics Limited and provision of guarantees/put options, amongst other matters. The above-mentioned information will also be available on website of the Company at www.biocon.com. Request you to take the above intimation on record.

pdf

Biocon Ltd.

21 Apr 2023

358.75

-0.21%

Company Update

BIOCON LTD. - 532523 - Submission Of Amended Biocon India Limited Employees Welfare Trust Deed

BSE India

This is further to our letter dated November 18, 2021, wherein the amended Biocon India Limited Employees Welfare Trust Deed was submitted by the Company with the Exchanges. Now, pursuant to Regulation 3(3) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, we would like to inform you that the Biocon India Limited Employees Welfare Trust Deed has been modified to take into the effect of the change of Trustees of the Biocon India Limited Employees Welfare Trust. Accordingly, we are enclosing herewith a copy of the amendment to the Articles of the trust deed of Biocon India Limited Employees Welfare Trust. Kindly take the same on record and acknowledge.

pdf

Biocon Ltd.

20 Apr 2023

358.75

-0.21%

Company Update

BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure …

BSE India

Meeting conducted with Institutional Investors/Research Analysts.

pdf

Biocon Ltd.

20 Apr 2023

358.75

-0.21%

Board Meeting

BIOCON LTD. - 532523 - Board Meeting Intimation for Intimation For The Board Meeting

BSE India

BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 23, 2023, inter alia, to approve and take on record the audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2023 and to consider recommendation of dividend, if any, amongst other routine matters.

pdf